Stephen Mandel Eli Lilly & CO Transaction History
Lone Pine Capital LLC
- $10.9 Billion
- Q1 2025
A detailed history of Stephen Mandel (Lone Pine Capital LLC) transactions in Eli Lilly & CO stock. As of the latest transaction made, Lone Pine Capital LLC holds 551,827 shares of LLY stock, worth $414 Million. This represents 4.19% of its overall portfolio holdings.
Number of Shares
551,827
Previous 782,860
29.51%
Holding current value
$414 Million
Previous $604 Million
24.59%
% of portfolio
4.19%
Previous 4.75%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,390Shares Held
821MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$76.1 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$72.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$59.5 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.4 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$25.9 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $713B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...